Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Analytical Science

Manufacture Analytical Science

Bringing Time Back to Biology

| Robert Karlsson

Surface plasmon resonance has become a go-to tool for biotherapeutic characterization.

Manufacture Analytical Science

Making a Difference to Drug Discovery

| James Strachan

DMS could make early drug discovery cheaper, faster and more efficient.

Discovery & Development Biosimilars

Proving Biosimilarity

| Fiona Greer

Sitting Down With... Fiona Greer, a biosimilar guru from SGS.

Manufacture Quality & Compliance

The Bioprocess Model Maker

| Jarka Glassey

What separates a good model from a bad model in bioprocess development?

Manufacture Analytical Science

Standing Up for Microcalorimetry

| Natalia Markova

We investigate the advantages and limitations of microcalorimetry in biopharma.

Discovery & Development Analytical Science

Relating the Geno to the Pheno

| James Strachan

Health data analytics help unravel the biology behind Alzheimer’s and Schizophrenia.

Discovery & Development Business Practice

In-vitro bioequivalence studies

The Morphologi G3-ID can be used to compare the Active Pharmaceutical Ingredients (API) within oral solid dose formualtions. Here we apply it to comparing innovator and generic versions of a product containing two APIs.

Discovery & Development Analytical Science

Finding Fakes

| Ravi Kalyanaraman

Looking at the past, present and future of counterfeit drugs screening.

Discovery & Development Business Practice

Top five reasons to replace a viscometer with a rheometer

Is your viscometer approaching the end of its life? Are you starting to feel that your trial and error, ‘rheology-light’ approach to formulation is becoming dated? Or are there longstanding product performance issues that you’re failing to gain traction with, where you suspect rheology may hold the answer? 

Discovery & Development Business Practice

Dry Powder Inhaler Formulation Development

Dry powder inhalers are accepted as being complex drug products due to the interactions which occur between the active pharmaceutical ingredients (APIs) and excipients within the formulation and the way this then affects the efficiency of drug delivery by the inhaler device. Obtaining component specific particle size and particle shape distribution data can help with understanding the properties of the formulation as part of formulation or deformulation studies. This application note describes how the combination of automated image analysis with Raman spectroscopy in the Morphologi G3-ID allows the individual components present within a dry powder inhaler formulations to be independently characterized and compared.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register